Home › Companies › Insmed Incorporated › 2025-2026
Compiled from SEC Form N-PX filings and Insmed Incorporated’s Form 8-K, filed 2026-05-15 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Insmed Incorporated in the interactive database Compare manager voting policies
These tallies are Insmed Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Elizabeth McKee Anderson | 153,734,471 | -- | -- | 32,130,980 | 11,564,082 | Majority: yes |
| Elect Director: Clarissa Desjardins, Ph.D. | 164,437,828 | -- | -- | 21,427,623 | 11,564,082 | Majority: yes |
| By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement: | 162,133,728 | 23,657,325 | 74,398 | -- | 11,564,082 | Majority: yes |
| By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026: | 190,386,612 | 6,997,613 | 45,308 | -- | -- | Majority: yes |
Source: Insmed Incorporated, Form 8-K, filed with the SEC on 2026-05-15 — read the filing on EDGAR.
Each item below shows how the 631 asset managers that disclosed a Insmed Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Insmed Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 10 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Insmed Incorporated’s own tally for this item (“By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement:”): 162,133,728 for, 23,657,325 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 216,521,841 outstanding shares: 75% for, 11% against (86% of the company cast a for/against vote).
The 628 asset managers below cast 89% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 25,974,145 | 703,849 | 0 | 0 | For |
| Vanguard | 21,721,388 | 96 | 0 | 0 | For |
| Darwin Global Management, Ltd. | 0 | 17,163,874 | 0 | 0 | Against |
| JPMorgan | 14,767,034 | 0 | 0 | 0 | For |
| BlackRock | 13,597,696 | 44 | 0 | 0 | For |
| Invesco | 13,298,707 | 0 | 0 | 0 | For |
| Capital Group | 9,535,294 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,909,331 | 709,560 | 0 | 0 | For |
| Artisan | 5,394,759 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 4,842,880 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,412,370 | 0 | 0 | 0 | For |
| State Street | 4,372,067 | 0 | 0 | 0 | For |
| Orbis Allan Gray Ltd | 2,605,782 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,400,080 | 0 | 0 | 0 | For |
| Charles Schwab | 2,147,536 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,946,885 | 29,390 | 0 | 0 | For |
| DE Shaw | 1,720,005 | 0 | 0 | 0 | For |
| American Century | 1,435,172 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,176,583 | 0 | 0 | 0 | For |
| Northern Trust | 1,113,704 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 1,076,813 | 0 | 0 | 0 | For |
| Victory Capital | 1,058,300 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 1,008,266 | 0 | 0 | 0 | For |
| Amundi | 0 | 992,373 | 0 | 0 | Against |
| Federated Hermes | 911,823 | 2,874 | 0 | 0 | For |
Showing the 25 largest of 628 asset managers. See all 628 in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Insmed Incorporated’s own tally for this item (“By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”): 190,386,612 for, 6,997,613 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 216,521,841 outstanding shares: 88% for, 3% against (91% of the company cast a for/against vote).
The 158 asset managers below cast 99.8% of the shares they voted on this item FOR (86,761,511 for, 167,782 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,062,933 | 16,918 | 0 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,221,489 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 650,188 | 0 | 0 | 0 | For |
| State Street | 606,327 | 21 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 505,585 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.
Combines 12 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Insmed Incorporated’s own tally for this item (“Elect Director: Clarissa Desjardins, Ph.D.”): 164,437,828 for, 21,427,623 withheld, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 216,521,841 outstanding shares: 76% for, 10% withheld (86% of the company cast a for/withheld vote).
The 155 asset managers below cast 100% of the shares they voted on this item FOR (83,945,510 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,079,762 | 0 | 90 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 2,221,489 | 0 | Abstain |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 650,188 | 0 | 0 | 0 | For |
| State Street | 606,348 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 327,172 | 0 | 178,413 | 0 | For |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.
Combines 13 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Insmed Incorporated’s own tally for this item (“Elect Director: Elizabeth McKee Anderson”): 153,734,471 for, 32,130,980 withheld, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 216,521,841 outstanding shares: 71% for, 15% withheld (86% of the company cast a for/withheld vote).
The 155 asset managers below cast 100% of the shares they voted on this item FOR (82,965,811 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,062,833 | 0 | 17,019 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 2,221,489 | 0 | Abstain |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 647,765 | 0 | 2,423 | 0 | For |
| State Street | 1,752 | 0 | 604,596 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 327,172 | 0 | 178,413 | 0 | For |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.
100% fund support · no official result
The 5 asset managers below cast 100% of the shares they voted on this item FOR (121,601 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Brighthouse | 77,928 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 23,487 | 0 | 0 | 0 | For |
| Franklin Alternative Strategies Funds | 10,046 | 0 | 0 | 0 | For |
| Putnam | 10,046 | 0 | 0 | 0 | For |
| Meeder Funds | 94 | 0 | 0 | 0 | For |
Ranked by the number of Insmed Incorporated shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 216,521,841 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.32% |
| 2 | Vanguard | 10.03% |
| 3 | Darwin Global Management, Ltd. | 7.93% |
| 4 | JPMorgan | 6.82% |
| 5 | BlackRock | 6.28% |
| 6 | Invesco | 6.14% |
| 7 | Capital Group | 4.40% |
| 8 | T. Rowe Price | 2.60% |
| 9 | Artisan | 2.49% |
| 10 | RTW INVESTMENTS, LP | 2.24% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| JPMorgan Chase | 11.15% | 13F |
| Vanguard Group | 9.73% | 13F |
| BlackRock | 7.70% | 13F |
| FMR (Fidelity) | 6.08% | 13F |
| Darwin Global Management, Ltd. | 2.97% | 13G |
| D.E. Shaw | 2.61% | 13F |
| State Street | 2.56% | 13F |
| T. Rowe Price | 1.43% | 13F |
| Franklin Templeton | 1.21% | 13F |
Percentages above are of 216,521,841 shares outstanding, as reported by Insmed Incorporated on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Insmed Incorporated’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Insmed Incorporated's shareholder meeting held 2026-05-13, in the 2025-2026 proxy season, 631 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,730 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory vote on the 2025 compensation of our named executive officers. — FOR was 87% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Insmed Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-15.
Insmed Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).